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Introduction 
Potassium channels play an important role for reab- 
sorptive and secretory pathways in the gastro-intes- 
tinal tract. Over the last years molecular identification 
and functional characterization of K + channels led to 
a better understanding of physiology and disease of 
intestinal transport. In gastric parietal cells KCNJ10 
(Kir4.1) and heteromeric KCNE2/KCNQI (MirP1/ 
KvLQT1), K + channels co-localize with the acid- 
producing H+/K + ATPase in the luminal membrane 
compartment. Specific K + channel blockage and ge- 
netical disruption of the KCNQ1 gene in mice inhibit 
acid secretion almost completely. In small intestine, 
K + channels provide the driving force for electrogenic 
reabsorption of nutrients in villus cells and secretion 
in intestinal crypt cells and they play an important 
role during cell volume regulation. In the colon, lu- 
minal K + channels repolarize the membrane and 
support electrogenic Na + reabsorption. In addition, 
they influence the final ionic composition of the feces. 
CaZ+-regulated KCNN4 K + channels and KCNE3/ 
KCNQ1 (MiRP2/KvLQT1) K + channels are local- 
ized in the basolateral membrane of crypt cells in 
small and large intestine. The KCNE3/KCNQ1 
channel complex is activated by cAMP during secre- 
tory diarrhea, i.e., via cholera toxin. Tissue-specific 
modulation of intestinal K + channels could offer new 
therapeutic perspectives for the treatment of life- 
threatening forms of diarrhea or peptic ulcer disease. 
Multifaceted Functions of K + Channels 
Potassium channels are expressed in practically all 
mammalian cells. They are membrane proteins with 
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two, four or six transmembrane domains and have 
in common a pore-forming loop that is part of the 
K +-selective filter [22]. Additional regulatory 
subunits and hetero-multimerization are important 
for membrane targeting, pharmacology, and func- 
tional properties [1, 2, 5, 103, 114, 116, 140]. Very 
recently, fascinating structural data shed light on 
the molecular principles of K + channel structure 
and function [58, 59]. Helpful overviews on the 
molecular diversity and nomenclature of the about 
85 different K + channel genes are available online 
at http://www, gene.ucl.ac.uk/nomenclature/gene- 
family/KCN.shtml and at http://www.ipmc.cnrs.fr/ 
~duprat/. 
This review focuses on the physiological and 
pathophysiological role of K + channels in epithelial 
cells of the gastro-intestinal tract. In intestinal epi- 
thelia K + channels are involved in different cellular 
function. 
HYPERPOLARIZATION AND GENERATION OF DRIVING 
FORCE FOR ELECTROGENIC TRANSPORT 
Opening of basolateral K + channels leads to a shift of 
the membrane voltage towards the Nernst potential 
for K +, which at the basolateral side is in the range of 
-90  inV. K + is then recycled by the Na+/K + ATPase. 
The hyperpolarization increases the driving force for 
electrogenic transport: Since the paracellular path- 
way of the intestinal epithelium is relatively leaky and 
does not completely isolate the luminal from the ba- 
solateral side, a paracellular short-circuit current (Isc) 
is induced by the transepithelial voltage difference 
(Vto) [36]. Thus, the basolateral K + channel-induced 
hyperpolarization is conducted to the luminal mem- 
brane and hyperpolarizes this membrane. By this 
mechanism, opening of basolateral K + channels 
supports basolateral and luminal electrogenic trans- 
port (Fig. 1) [41, 75]. Besides Vte, the paracellular ion 
flux depends on the specific ionic permeability of the 
paracellular barrier, which differs along the intestinal 
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Fig. 1. Role of K + channels during electrogenic transport. (A) A 
simplified circuit model for an epithelial cell layer (modified from [40, 
41]). For simplification, Na+/K § ATPase pump current and para- 
cellular diffusion potential have been omitted. Abbreviations: Vt~, 
transepithelial voltage; Va, apical membrane voltage, Vbl, basotateral 
membrane voltage; l~c, short circuit current over the paracellular 
resistance; Ra apical membrane resistance; Rbl , basolateral mem- 
brane resistance; Rs, paracellular shunt resistance; E~, electrochem- 
ical driving force of  the apical membrane; Ebl, electrochemical 
driving force of the basolateral membrane. (B) In a theoretic epi- 
thelium having only luminal CI , basolateral K + channels, and no 
paracellular conductance, Isc equals 0. Va and Vbl are determined by 
the Nernst equilibrium for CI- and K § , respectively. Neither C1 nor 
K* leaves the cell because the driving force is missing. Despite a high 
Vte no transepithelial ion flux can occur. (C) Addition of a paracel- 
lular Na § permeability to model B leads to Na + flux to the lumen 
driven by Vte. This 1s~ attenuates Vte, hyperpolarizes the luminal and 
depolarizes the basolateral membrane, resulting in Cl-  and K ~ exit 
to the luminal and basolateral side, respectively: The epithelium se- 
cretes NaC1. (D) Additional activation of  a luminal K + conductance 
ensues in electroneutral transcellular KCI secretion and further re- 
duces V~e, thereby diminishing paracellular Na + flux. For a reab- 
sorptive epithelium the luminal CI conductance in models C and D 
has to be replaced by electrogenic transport systems such as Na ~- 
dependent glucose or amino-acid transport. In such an epithelium, a 
C1 -selective paracellular conductance would cause paracellular CI 
reabsorption, resulting in transepithelial reabsorption of substrates, 
Na ~ , and CI-. Water follows along the osmotic gradient. 
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tract, depending on the composition of barrier- 
forming proteins [23, 105]. 
K + SECRETION AND FINE-TUNING OF SALT 
METABOLISM 
Luminal K + channels directly hyperpolarize the 
apical membrane and lead to K + secretion into the 
lumen. In contrast to basolateral K + channels, ac- 
tivation of luminal K + channels decreases Vte, 
thereby reducing the driving force for paracellular 
transport of ions. Luminal K + channel activity in 
distal colon and distal renal nephron segments plays 
an important role for K + excretion and Na + reab- 
sorption [3, 76]. These segments determine the final 
ion composition of feces and urine and are mainly 
regulated by the mineralocorticoid aldosterone and 
K + intake. 
RECYCLING OF K + ACROSS THE LUMINAL 
MEMBRANE 
In gastric parietal cells and to less extent in colonic 
surface cells, luminal K + channels are required to 
recycle K + that has been taken up by H+/K + ATP- 
ases [37, 137]. In gastric glands, inhibition of the K +- 
recycling channel blocks H+/K + ATPase activity and 
hence gastric acid secretion almost completely [38]. 
CELL VOLUME REGULATION 
Transport of osmolytes and osmotic gradients across 
the luminal membrane represent a continuous chal- 
lenge for volume regulation in intestinal cells. Upon 
hypotonic swelling, activation of K + channels allows 
reduction of the concentration of intracellular osm- 
olytes, thereby performing regulatory volume de- 
crease [121]. In contrast, cell shrinkage leads to 
inhibition of K + channels. Thus, volume regulation- 
induced changes of K + channel activity can directly 
affect transepithelial ion transport [109, 137]. Several 
cloned K + channels that are expressed in intestinal 
epithelium are affected by changes in cell volume (i.e., 
KCNN4 [44, 137], KCNK5 [96], and KCNQ1 [73]). 
An excellent review on cell volume regulating mech- 
anisms is given in [68]. 
PROLIFERATION AND DIFFERENTIATION 
K + channel activity is dependent on cell cycle, pro- 
liferation and differentiation. There is some evidence 
that K + channels might be directly involved in the 
regulation of these processes [100, 141] and that 
pharmacological modulation of K § channels can 
change cellular fate [60]. Recently, activation of K + 
channels was observed in intestinal epithelial cells 
after wounding, which probably plays an important 
role for epithelial cell migration [107, 131]. During 
cancer genesis in colonic epithelium, changes in ion 
channel expression have been observed [12], It is of 
great interest to gain more insight into the mecha- 
nisms regulating the rapid cell renewal in the gastro- 
intestinal tract. However, at present it is not clear 
whether the changes in ionic conductances are mainly 
secondary effects or whether the ionic properties in- 
terfere with the cellular fate in a more direct way. 
Although all of the above mentioned different 
functions of K + channels are of importance, we will 
focus in this review on the major task of the gastro- 
intestinal epithelium: transport of substrates, salt and 
water. 
Luminal K + Channels Are Required for Acid 
Secretion in Gastric Parietal Cells 
In stomach mucosa, acid secretion occurs in a spe- 
cialized cell type, the parietal cell. These mitochon- 
dria-rich cells have a unique morphology with 
invaginations of the luminal membrane into the cy- 
toplasm and complex vesicular structures, so-called 
tubulocisternae, which amalgamate with the luminal 
membrane upon secretory stimuli [31]. The acid- 
producing enzyme H+/K+-ATPase is localized in 
these tubulocisternae. After amalgamation with the 
luminal membrane, the H+/K+-ATPase pumps H + 
out of the cell, paralleled by an uptake of K +. C1- is 
secreted into the lumen via apical C1C-2 C1- chan- 
nels [82, 123]. To avoid K + depletion of the luminal 
fluid due to H+/K + ATPase activity, a recycling 
pathway for K + is required (Fig. 2A). There is good 
experimental evidence that K + channels are the 
respective pathway [46, 138, 139]. In immunofluo- 
rescence experiments the KCNQ1 K + channel (for- 
merly named KvLQT1) showed an H+/K+-ATPase - 
like distribution pattern in human parietal cells (Fig. 
2B) [24, 38]. Its pharmacological inhibition by the 
chromanol 293B abolished acid secretion almost 
completely in vitro and in vivo. Most likely, KCNQ1 
is associated with its regulatory subunit KCNE2 
(MiRP1) to form the native channel complex [24, 38]. 
The functional role of KCNQ1 for acid secretion was 
underlined by observations in KCNQ1 knockout 
mice, which have an impaired acid secretion leading 
to hypergastrinemia and glandular gastric hypertro- 
phy [69]. At present, it is not known whether homo- 
zygous KCNQ1 mutations in patients suffering from 
so-called Jervell-Lange-Nielsen syndrome [95] also 
lead to defects in gastric acid secretion. Very recently, 
another K + channel was described in parietal cells: 
Immunofluorescence experiments and electron mi- 
croscopy revealed a localization of KCNJ10 (Kir4.1) 
in the H+/K+-ATPase-containing membrane com- 
partment, suggesting that besides KCNQI also 
KCNJ10 might play a role during acid secretion [37]. 
To date no data are available concerning the gastric 
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Fig. 2. K + recycling is required for acid secretion in parietal cells. 
(A) Functional and morphological changes of a parietal cell during 
stimulation of  acid secretion. In the absence of  secretory stimuli 
H+/K + ATPase is located in intracellular vesicular structures (so- 
called tubulocisternae [31]). At present, it is not known whether K + 
channels, required for K + recyling, are located in H+/K + ATPase- 
containing vesicles or in separate vesicular structures. A connection 
of  the tubulocisternae to the lumen does not yet exist. Upon 
stimulation via cAMP and IP3/Ca 2+ pathways, tubulocisternae get 
fused with the luminal membrane, thereby enlarging the luminal 
surface and targeting H+/K+-ATPases and K + channels to the 
apical side. Now K + channels get activated by increasing concen- 
trations of  cAMP and cytosolic Ca 2+, and allow K + recycling, 
which is necessary for ongoing H+/K+-ATPase activity. (B) lm- 
munofluorescence of a resting human parietal cell with labeling of 
H+/K +-ATPases (left) and KCNQ 1 K + channels (right). Both show 
a granular distribution pattern within the cell, suggesting a locali- 
zation of the proteins in vesicles and tubulocisternae, which belong 
to the luminal membrane compartment. 
phenotype of KCNJ10 knockout mice [85]. Further 
studies are required to elucidate nature, function and 
membrane targeting of luminal K + channels during 
gastric acid secretion. 
In the basolateral membrane the C1-/HCO 3 ex- 
changer serves C1- uptake and HCO 3 extrusion. 
Basolateral Na+/H + exchangers stabilize intra- 
cellular pH and cell volume [110, 118]. With the 
patch-clamp technique, K + conductances have been 
observed in the basolateral membrane and in whole- 
cell experiments [25, 90]; in whole-cell experiments 
[63], however, it is at present not clear whether they 
provide the driving force for voltage-dependent ba- 
solateral transport or for luminal C1- exit. For the 
latter function paracellular permeability would be 
required (see Fig. 1), which has been shown to be 
rather low [36]. 
Function of K + Channels for Reabsorption 
and Secretion in Small Intestine 
In small intestine most of the nutrients are digested 
and consecutively absorbed. The largest part of the 
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Fig. 3. Electrogenic transport in small intestine. (A) The mucosa of 
small intestine consists of crypt and villus cells. Reabsorption takes 
mainly place at the brushborder membrane of villus enterocytes. 
Goblet cells produce mucus, crypt cells secrete HCO 3-rich fluid to 
neutralize gastric acid. Stem cells for the rapid regeneration of 
enterocytes are localized at the crypt basis. (B) In the luminal 
membrane of villus cells, glucose and amino acids are reabsorbed in 
a secondary active way together with Na +. This depolarizes the 
luminal membrane, leading to the generation of a lumen-negative 
transepithelial voltage (Vte), which can drive reabsorption of anions 
via the paracellular pathway. Luminal K + channels could play a 
role for repolarization [134]. There is also some evidence for an 
H+/K + exchange mechanism, probably via H+/K + ATPase [9]. The 
molecular identity of luminal and basolateral K + channels is not 
known. The intermediate-conductance K + channel is probably less 
expressed in the basolateral membrane of villus cells when corn- 
pared with crypt cells [47]. C1C-2 C1 channels seem to mediate 
paraceltular C1- fluxes [45] driven by the electro-chemical gradient. 
(C) Secretion in crypt cells requires activation of luminal C1- 
channels (CFTR), basolateral (and luminal) K + channels, NKCC1 
and Na+/K + ATPase [42, 125]. Heteromultimeric KCNE3/KCNQ1 
channels represent a cAMP-activated K + conductance. Their in- 
hibition largely attenuates electrogenic C1 /HCO 3 secretion. The 
intermediate-conductance K + channel (probably KCNN4) is acti- 
vated via increases in cytosolic Ca 2+. HCO 3 leaves the cell via 
CFTR and via luminal anion exchangers (probably DRA). On the 
basolateral side, CI can be taken up by NKCC1 and by Na +- 
dependent and -independent anion exchangers (AE2 and NBC) 
[130]. Luminal C1 and basolateral K + conductance create a lu- 
men-negative Vte, that possibly induces paracellular Na + fluxes. 
The mechanisms for HCO 3 secretion are probably present in villus 
cells, too (B). 
fluid is r e abso rbed  by  the small  in tes t inal  mucosa  and  
only some 20% enter  the colon.  The mass  t r anspo r t  in 
the small  intest ine involves bo th  t ranscel lu lar  and  
parace l lu la r  t r a n s p o r t  o f  solutes,  ions and  water.  In  
o rder  to fulfill different phys io logica l  demands ,  the 
reabsorp t ive  capac i ty  o f  small  intes t inal  mucosa  is 
regula ted  by  t ransc r ip t iona l  and  non- t r ansc r ip t iona l  
mechanisms .  Thus,  express ion o f  t r anspor te r s  and  
ion channels  can vary  over  a b r o a d  range,  depend ing  
on the needs [53, 64, 97, 99]. 
A m o n g  the t ranscel lu lar  mechanisms,  secondary  
active t r anspo r t  al lows abso rp t i on  o f  subs t ra tes  even 
agains t  a concen t ra t ion  gradient ,  i.e., by  N a + - c o u  - 
p led t r anspor te r s  for  glucose and amino  acids. M a n y  
o f  the t r anspor te r s  use the chemical  g rad ien t  for  N a  § 
or  H § and  the negat ive  m e m b r a n e  vol tage  as dr iv ing 
forces [86, 98]. The entry  o f  a posi t ive net  charge  via 
these systems depolar izes  the lumina l  m e m b r a n e  o f  
enterocytes ,  leading to a t ransepi the l ia l  vol tage  dif- 
ference (Vte, s e e  Fig. 1 and  Fig.  3) and  consecut ively  
to pa race l lu la r  e lectrogenic  t r anspor t ,  i.e., t r an spo r t  
o f  C1- [8, 45]. However ,  the depo la r i za t ion  o f  the 
luminal  m e m b r a n e  reduces fur ther  vo l t age -dependen t  
t ransce l lu lar  t ranspor t .  To restore the t r anspo r t  ca- 
pac i ty  o f  the enterocytes ,  K § channels  are requi red  to 
repolar ize  the m e m b r a n e  voltage.  They can be local-  
ized in ei ther  the lumina l  or  the baso la te ra l  mem- 
brane  o f  villus cells (Fig. 3). I t  has been shown tha t  
ac t iva t ion  o f  baso la te ra l  K § channels  by pinacidi l  or  
B R L  38227 increases NaC1 reabsorp t ion ,  para l le led  
by an enhanced  shor t -c i rcui t  cur rent  [51]. S t rong ac- 
t iva t ion  o f  luminal  K § channels ,  e.g., by cell swelling 
[80], could  even p roduce  a lumen-pos i t ive  t ransepi-  
thel ial  vol tage,  which in turn  would  invert  the direc- 
t ion o f  pa race l lu la r  ion fluxes [45]. In  ano the r  s tudy,  a 
nitr ic ox ide-ac t iva ted  baso la te ra l  K § conduc tance  
was descr ibed,  whose ac t iva t ion  by the K § channel  
opener  c r o m a k a l i m  enhanced  net  fluid r eabso rp t ion  
72 R. Warth and J. Barhanin: K ~ Channels of the Intestinal Epithelium 
Fig. 4. KCNE3/KCNQI K + channels in mouse jejunum. (A) Im- 
munolocalization of KCNQI in mouse jejunum (overlay with dif- 
ferential interference contrast image). The KCNQl-specific 
antibody [134] preferentially labeled the basolateral membrane of 
jejunal crypts cells. (B) Effect of the chromanol 293B on cAMP- 
activated secretion in mouse jejunum. Forskolin at 5 gM (FSK) 
increased transepithelial voltage (Vte) mainly by activation of lu- 
minal C1 and basolateral KCNE3/KCNQ1 K ~ channels. 293B 
reduced Vtc concentration-dependently by some 70%. Carbochol 
100 gM (CCH) led to a rise in Vte by transiently activating Ca 2+ 
activated K § channels (probably KCNN4). AVte is a measure for 
transepithelial resistance. 
[115], indicating that luminal and basolateral K + 
conductances support reabsorption in small intestinal 
villus cells. 
In the crypts of the small intestine, net secretion 
of bicarbonate, mucus, salt and water occurs, which 
allows buffering of acidic gastric content and facili- 
tates propulsion of the intestinal content. Under 
pathological conditions, overwhelming activation of 
secretion, i.e., by cholera toxin, can lead to severe 
diarrhea. Transcellular transport in crypt cells is 
mainly a serosal-mucosal flux of CI-, HCO 3 and K + 
[130], which is activated via cAMP and C a  2+ path- 
ways and to some extent via nitric oxide/cGMP [6]. 
Bicarbonate secretion plays an important role for 
mucosal protection and neutralization of gastric acid. 
However, the luminal pathway for bicarbonate exit is 
controversially discussed: It probably involves elec- 
trogenic systems such as CFTR channels (cystic fi- 
brosis transmembrane conductance regulator) [21] 
and electroneutral C1 /HCO 3 exchangers such as 
DRA (down-regulated in adenoma) [50, 55, 93, 104]. 
The amount of HCO 3 secreted via electrogenic 
transport systems is dependent on the membrane 
voltage and, thus, on K + channel activity. For 
the maintenance of electro-neutrality, Na + enters the 
lumen via the paracellular pathway driven by the 
transepithelial voltage, and K + can be secreted via 
luminal K + channels (Fig. 3C). 
Transcellular mass transport of nutrients, salt, 
and water is a continuous challenge for cellular vol- 
ume regulation of enterocytes in small intestine. 
There is good evidence that K + channels play a role 
during regulatory volume decrease after swelling of 
villus enterocytes [79]. Moreover, it has been shown 
that Na+-dependent absorption of amino acids in 
enterocytes leads to activation of Na+/K + ATPase 
and of basolateral K + channels. The increase in ba- 
solateral K + conductance prevents rises in intracel- 
lular K + concentration (due to enhanced Na+/K + 
ATPase activity) and counteracts the depolarization 
caused by luminal electrogenic transport activity [39]. 
Compared with colonic K + channels, relatively 
little is known about the functional properties and the 
molecular identity of K + channels in the small in- 
testine (Fig. 3) [124]. With electrophysiological 
methods several basolateral K + channels could be 
distinguished: an abundant large conductance 
"maxi" K + channel (90 to 250 pS) [15, 92, 122], an 
intermediate-conductance, CaZ+-activated K + chan- 
nel, small-conductance channels [15], KATp-like 
channels [30] and a chromanol 293B-sensitive K + 
conductance [134]. The regulation of the large-con- 
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Fig. 5. Role of K + channels for secretion and absorption in distal 
colonic mucosa. (A) Colonic crypts consist of enterocytes, entero- 
endocrine cells and goblet cells. Absorption of short-chain fatty 
acids, salt, and water takes place in surface cells and the upper part 
of the crypt. At the crypt base, secretion and mitosis take place. (B) 
In surface cells Na § enters the cell via ENaC and is exported via 
basolateral Na+/K + ATPase. CFTR CI channels are less abun- 
dant than in crypt base cells. Without luminal K + channel activity, 
ENaC-induced luminal depolarization leads to CI reabsorption 
via CFTR. Activation of luminal K + channels results in K + se- 
cretion paralleled by luminal hyperpolarization. If the luminal 
membrane voltage is more negative than the CI equilibrium po- 
tential, the direction of the CFTR C1 flux would invert: the cell 
secretes KC1 and reabsorbs Na +. Luminal H+/K + ATPase serves 
mainly K + reabsorption. Basolateral K + channels provide a part of 
the driving force for luminal ion movement. (B) In crypt base cells, 
secretion requires cAMP-dependent activation of luminal CFTR 
C1- channels and of basolateral KCNE3/KCNQ1 K + channels. 
Ca 2+ leads to activation of basolateral KCNN4 K + channels but 
requires a certain level of luminal CFTR activity to induce C1 
secretion, because CFTR seems not to be directly Ca2+-activated. 
Ca 2 +-activated CI- channels play a minor role in normal tissue but 
can be observed during tumor genesis in colonic mucosa [12]. 
Driven by the transepithelial voltage, Na + follows via the para- 
cellular pathway. 
ductance K + channel by cAMP and Ca 2+ is con- 
troversially discussed [15, 87, 92, 122]. The interme- 
diate-conductance K + channel is strongly activated 
by rises in cytosolic Ca 2+ and by 1-ethyl-2-benzimi- 
dazolinone (1-EBIO) and shows functional charac- 
teristics similar to cloned IK1 channels (KCNN4) 
[47], suggesting that KCNN4 is the intermediate- 
conductance K + channel as found in rat colonic 
crypts [135]. There is some evidence for a regulation 
of the intermediate-conductance K + channel by 
cAMP [87], however, in another study no such reg- 
ulation was observed [15]. Activation of this channel 
by 1-EBIO leads to a strong increase in C1 secretion 
but does not affect phloridzin-sensitive glucose ab- 
sorption indicating that the 1-EBIO-activated K + 
channel is mainly expressed in intestinal crypts and 
not or only little in villus cells [47]. 
The 293B-sensitive conductance is mainly located 
in crypt cells and formed by KCNQ1/KCNE3 
channel proteins (Figs. 3C and 4A) [24, 134]. The 
KCNE3/KCNQ1 channel complex is activated dur- 
ing cAMP-stimulated secretion. Its inhibition blocks 
electrogenic jejunal secretion by some 50-70% (Fig. 
4B). Thus, KCNE3/KCNQ1 channels are a possible 
target for the treatment of life-threatening forms of 
secretory diarrhea, such as cholera. The 293B deriv- 
ative IKs224 was shown to inhibit jejunal secretion 
with an IC5o in the nanomolar range [134]. However, 
clinical use of KCNE3/KCNQ1 blockers would re- 
quire subunit specificity and/or locally restricted de- 
livery of the drug, since one has to avoid inhibition of 
KCNE1/KCNQ1 channels in heart and inner ear. 
K + Channels in Colonic Mucosa 
In contrast to mass transport in small intestine, the 
colonic mucosa serves the fine tuning of salt and 
water metabolism. Under physiological conditions 
absorption largely exceeds secretion: Some 90% of 
1.51 of intestinal content entering the colon are 
absorbed and only 150-200 g are excreted under 
physiological conditions. However, a certain level of 
secretion of mucins, electrolytes and water is 
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required for normal transport and composition of 
feces. Thus, defects in secretion, i.e., in cystic 
fibrosis, can lead to severe constipation. On the 
other hand, impairment of colonic reabsorption 
leads to diarrhea, affecting salt/water and acid/base 
metabolism [67]. 
In the proximal part, Na + is mainly reabsorbed 
via Na +/H + exchangers and in distal colon, via Na + 
channels (ENaC). Depending on the needs of me- 
tabolism and hormone concentrations, K + can be 
net-secreted via channels or reabsorbed by a luminal 
H+/K+-ATPase (Fig. 5) [10, 34, 89, 120]. A detailed 
list of hormones and mediators regulating colonic 
transport is given in [133]. Moreover, bacterial deg- 
radation of undigested nutrients leads to generation 
of short-chain fatty acids and ammonia, which are 
taken up by cells located at the surface of colonic 
crypts [17, 18, 48]. 
K + channels play a role for secretory and re- 
absorptive pathways. In particular the activity of 
luminal K + channels affects the K + balance of the' 
body and therefore is regulated via K + intake and 
different hormones. In the presence of high potas- 
sium diet [16, 113] or high aldosterone concentra- 
tions [35, 43, 76, 81], K + channels hyperpolarize the 
luminal membrane of crypt cells, leading to electro- 
neutral transcellular secretion of KC1 instead of 
transcellular C1 exit and paracellular Na + flux (Fig. 
ID). In surface epithelial cells, the K + channel-in- 
duced hyperpolarization increases the driving force 
for Na + uptake via ENaC in distal colon. These K + 
conductances are modulated by cholinergic and 
cAMP-mediated pathways [29, 49, 84, 119]. Direct 
functional characterization of luminal K + channels 
with the patch-clamp technique is hampered by 
mucus and microvilli, which make measurements 
very difficult. There is evidence for large-conduc- 
tance K + channels with single-channel conductances 
from 120-230 pS [16, 113, 133] and for a pH-sensi- 
tive ROMK-type channel [52, 62, 133]. Data from 
KCNMA1 knockout mice indicate that maxi K + 
channels play a role in K + secretion after purinergic 
receptor stimulation [70]. The inhibitory effect of the 
chromanol 293B on cAMP-activated serosal-to-mu- 
cosal Rb + flux suggests that KCNQ1 might be lo- 
calized in luminal and basolateral membranes [29]. 
In the luminal membrane, KCNQ1 could co-as- 
semble with the small regulatory proteins KCNE1 or 
KCNE2 [1321. 
In the basolateral membrane of colonic mucosa 
at least three different types of K + channels are 
present: (1) a large-conductance K + channel that is 
very abundant in rabbit colon [77, 78, 127]; (2) 
KCNN4 underlying the intermediate-conductance 
CaZ+-activated K + channel [14, 27, 135], and (3) 
KCNQ1, a very small-conductance K + channel that 
is stimulated via cAMP and blocked by 293B [11, 24, 
26, 65, 75, 117, 136]. 
Upon cholinergic stimulation of rat colonic mu- 
cosa, a strong but transient opening of KCNN4 
channels is observed, leading to hyperpolarization of 
the basolateral membrane. The basolateral hyperpo- 
larization increases the transepithelial potential dif- 
ference if the luminal membrane is depolarized by 
C1- channels [13, 49]. Interestingly, the Ca z+ path- 
way alone seems not to activate sufficiently the lu- 
minal C1- conductance in normal colonic mucosa: in 
the absence of cAMP-mediated activation of luminal 
C1- channels, cholinergic stimulation by carbachol 
inverts the polarity of the Vte and leads to a lumen- 
positive transepithelial voltage via activation of 
luminal K + channels [83]. However, during carcino- 
genesis, Ca2+-activated C1- channels are expressed, 
counteracting the hyperpolarizing effect of KCNN4 
channel opening [12] and thereby mimicking the ef- 
fect of carbachol in some colonic cell lines. Colonic 
KCNN4 channels are potently blocked by the anti- 
fungal drug clotrimazole and activated by 1-EBIO 
[28, 102, 129, 135]. Pharmacological activation and 
inhibition of colonic KCNN4 channels have been 
discussed as strategies for the treatment of cystic fi- 
brosis and diarrhea, respectively [28, 57, 111, 126]. 
Basolateral K + channel inhibition was claimed to 
mediate the effect of the antidiarrheal drug lopera- 
mide [33]. 
In large intestine cAMP-mediated secretion plays 
an important role for normal transport of feces, 
which is impaired in cystic fibrosis. On the other 
hand, some bacterial toxins, such as cholera toxin, 
induce an overwhelming secretion in small and large 
intestine [133]. It has been shown that cAMP de- 
creases intracellular Ca 2 + activity of colonocytes via 
depolarization-induced reduction of Ca z+ influx. 
Thus, KCNN4-type CaZ+-dependent K + channels 
are closed during cAMP-mediated secretion [13]. 
Under these conditions, the driving force for luminal 
C1- exit mainly depends on cAMP-activated KCNQ1 
K + channels. The KCNQ1 inhibition by 293B was 
shown to block the electrogenic part of C1 secretion 
(Fig. 1C) [75] and the minor electroneutral secretion 
of KC1 (Fig. 1D) [29]. Like in small intestine, KCNQ1 
is associated with its regulatory subunit KCNE3 in 
the basolateral membrane of colonic enterocytes. In 
contrast to the cardiac KCNE1/KCNQ1 channel 
complex, which is voltage-dependent and slowly ac- 
tivating, KCNE3/KCNQ1 channels are voltage-in- 
dependent and constitutively open [117]. 
More Intestinal K + Channels in the Future? 
During the last years a number of new K + channel 
transcripts, i.e., for several maxi K + channels and 
2-p-domain K + channels, have been found in the 
gastrointestinal tract and the list of intestinal K ~ 
channel genes (Table 1) is probably not complete. 
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On the other hand, for expression analysis, often 
commercially available samples of total tissue 
cDNA or RNA (including muscle layers and neu- 
ronal cells) were used. In these cases it is not 
proven that the respective K + channels are loca- 
lized in the epithelial cells. Only for a very limited 
number of channels epithelial expression, cellular 
localization and a functional role in the native tis- 
sue could be shown. However, these data led to a 
better understanding of transport in the intestinal 
tract and these channels could be targets of drug 
development for the treatment of transport-related 
diseases. 
Supported by a "Forschungskredit der Universitfit Ztirich" to 
R.W. 
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